Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities
2024年5月22日 - 2:33AM
ビジネスワイヤ(英語)
Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code
002821.SZ/6821.HK) announced today that it will operate the former
Pfizer U.K. small molecule API pilot plant and part of the
development laboratories through a new lease agreement between
Asymchem and Discovery Park, establishing Asymchem’s first
manufacturing footprint in Europe. Asymchem will continue to
operate the site in Sandwich, Kent, as a clinical small molecule
development and manufacturing facility to meet global client
demands for pharma services and supply.
The development laboratories are expected to begin operation in
June 2024, followed by the API pilot plant in August. The site is
expected to employ approximately 100 individuals by the end of
2024, including many staff previously employed by Pfizer. Planned
additions for the site include capabilities for the manufacture of
peptides and oligonucleotides, as well as sustainability
capabilities utilizing continuous flow and biocatalysis.
“We are excited to become a part of the European pharma
manufacturing community,” said Chairman and CEO of Asymchem Group,
Dr. Hao Hong. “Meeting the needs of our clients in bringing
manufacturing into the Western market will continue to be part of
our long-term strategy to meet overall global business
demands.”
Mayer Schreiber, CEO of Discovery Park, said: “We are delighted
to welcome Asymchem to Discovery Park this summer. The organisation
has selected Discovery Park as their European base and home to
their first manufacturing facility in Europe, bringing new jobs and
safeguarding scientific talent. Asymchem joins a burgeoning
community of over 160 companies in a designated Life Sciences
Opportunity Zone, representing an incredible talent pool which
contributes significantly to the U.K. life sciences economy.”
About Asymchem
Asymchem is a global technology-driven contract development and
manufacturing organization (CDMO) providing services to the
pharmaceutical industry. Founded in 1997, Asymchem employs over
9300 personnel world-wide, with R&D and manufacturing
operations in China and the U.S.
Forward-Looking Statements
This press release may contain certain forward-looking
statements that are, by their nature, subject to significant risks
and uncertainties. The words “anticipate”, “believe”, “estimate”,
“expect”, “intend” and similar expressions, as they relate to the
Company, are intended to identify certain of such forward-looking
statements. The Company does not intend to update these
forward-looking statements regularly. These forward-looking
statements are based on the existing beliefs, assumptions,
expectations, estimates, projections, and understandings of the
management of the Company with respect to future events at the time
these statements are made. These statements are not a guarantee of
future developments and are subject to risks, uncertainties, and
other factors, some of which are beyond the Company’s control and
are difficult to predict. Consequently, actual results may differ
materially from information contained in the forward-looking
statements as a result of a number of factors, including, without
limitation, future changes or developments in our business, the
Company’s competitive environment and political, economic, legal
and social conditions.
The Company, its directors and the employees assume (a) no
obligation to correct or update the forward-looking statements
contained in this announcement; and (b) no liability in the event
that any of the forward-looking statements does not materialize or
turn out to be incorrect.
About Discovery Park
Discovery Park is a thriving UK life science community for
visionary entrepreneurs and leaders. Within easy reach of London,
Discovery Park spearheads Kent’s flourishing science and technology
cluster.
Discovery Park offers state-of-the-art labs, modern offices and
manufacturing facilities, unrivalled flexibility and comprehensive
support including access to finance and a strong local talent
pool.
Discovery Park has been a major centre for life science for
nearly 70 years and is home to 160+ companies across a growing
tenant community of dynamic start-ups through to global
corporations. This includes Algaecytes, Canterbury Christ Church
University, Concept Life Sciences, eXroid, Genea Biomedx, LGC,
Pfizer, Psyros Diagnostics, Salvensis, Viatris, VisusNano and Wren
Healthcare.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240521088343/en/
Jake Knorr Senior Director of Marketing
jakeknorr@asymchem.com